Literature DB >> 27456360

MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.

Li Han1, Bo Liu2, Lixi Jiang2, Junyan Liu2, Shumei Han2.   

Abstract

Metastasis has become the main challenge for treatment of estrogen receptor alpha (ERα) negative breast cancer. Here, we found a negative correlation between miR-497 and estrogen-related receptor alpha (ERRα), a nuclear receptor overexpressed in ERα negative breast cancer. Targeted inhibition of ERRα by si-RNA increased miR-497 expression while overexpression of ERRα inhibited miR-497 expression. Further investigation showed that miR-497 targeted ERRα by binding to the 3'UTR region of ERRα. Luciferase assay and ChIP assay confirmed that ERα directly regulated the transcription of miR-497, suggesting that loss of ERα lowered miR-497 level in ERα negative breast cancer. Further, overexpression of miR-497 not only inhibited ERRα expression but also reduced MIF level and MMP9 activity, which led to significant decreases in cell proliferation, migration, and invasion of ERα negative breast cancer. Taken together, our findings suggested that, in ERα negative breast cancer, the low level of ERα reduced miR-497 expression, which promoted ERRα expression that enhanced cell proliferation, migration, and invasion by increasing MIF expression and MMP9 activity.

Entities:  

Keywords:  Breast cancer; Estrogen receptor alpha; Estrogen-related receptor alpha; Invasion; Migration; miR-497

Mesh:

Substances:

Year:  2016        PMID: 27456360     DOI: 10.1007/s13277-016-5200-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  42 in total

1.  Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin.

Authors:  Anaïs Fradet; Helène Sorel; Lamia Bouazza; Delphine Goehrig; Baptiste Dépalle; Akeila Bellahcène; Vincent Castronovo; Hélène Follet; Françoise Descotes; Jane E Aubin; Philippe Clézardin; Edith Bonnelye
Journal:  Cancer Res       Date:  2011-07-06       Impact factor: 12.701

Review 2.  Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.

Authors:  Geneviève Deblois; Vincent Giguère
Journal:  Nat Rev Cancer       Date:  2012-11-29       Impact factor: 60.716

3.  Transcriptional targets shared by estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta.

Authors:  J M Vanacker; K Pettersson; J A Gustafsson; V Laudet
Journal:  EMBO J       Date:  1999-08-02       Impact factor: 11.598

4.  MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.

Authors:  Min Luo; Dongxiang Shen; Xiaoning Zhou; Xiaodong Chen; Wei Wang
Journal:  Surgery       Date:  2013-02-28       Impact factor: 3.982

5.  MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.

Authors:  Chuankui Wei; Qifeng Luo; Xiaoguo Sun; Dengfeng Li; Hongming Song; Xiaoyu Li; Jialu Song; Kaiyao Hua; Lin Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

6.  Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.

Authors:  Takashi Suzuki; Yasuhiro Miki; Takuya Moriya; Norihiro Shimada; Takanori Ishida; Hisashi Hirakawa; Noriaki Ohuchi; Hironobu Sasano
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

7.  A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.

Authors:  Nicholas C D'Amato; Thomas J Rogers; Michael A Gordon; Lisa I Greene; Dawn R Cochrane; Nicole S Spoelstra; Travis G Nemkov; Angelo D'Alessandro; Kirk C Hansen; Jennifer K Richer
Journal:  Cancer Res       Date:  2015-09-11       Impact factor: 12.701

8.  miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.

Authors:  Zhihao Wu; Xiangli Li; Xuehong Cai; Chenggang Huang; Min Zheng
Journal:  Tumour Biol       Date:  2015-12-23

9.  Estrogen-related receptor α decreases RHOA stability to induce orientated cell migration.

Authors:  Juliette Sailland; Violaine Tribollet; Christelle Forcet; Cyrielle Billon; Bruno Barenton; Julie Carnesecchi; Alice Bachmann; Karine Cécile Gauthier; Shan Yu; Vincent Giguère; Franky L Chan; Jean-Marc Vanacker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

10.  MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.

Authors:  Lin Wang; Cheng-fei Jiang; Dong-mei Li; Xin Ge; Zhu-mei Shi; Chong-yong Li; Xue Liu; Yu Yin; Linlin Zhen; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Oncotarget       Date:  2016-01-19
View more
  11 in total

1.  MicroRNA-497 suppresses cell proliferation and induces apoptosis through targeting PBX3 in human multiple myeloma.

Authors:  Tianhua Yu; Xuanhe Zhang; Lirong Zhang; Yali Wang; Hongjuan Pan; Zhihua Xu; Xiaochuan Pang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.

Authors:  Juhua Zhuang; Ying Ye; Guoyu Wang; Jing Ni; Saifei He; Cuihua Hu; Wei Xia; Zhongwei Lv
Journal:  Mol Med Rep       Date:  2017-08-24       Impact factor: 3.423

3.  Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer.

Authors:  Tiphaine de Foucher; Maria Sbeih; Jenifer Uzan; Sofiane Bendifallah; Marine Lefevre; Nathalie Chabbert-Buffet; Selim Aractingi; Catherine Uzan; Issam Abd Alsalam; Rana Mitri; Romain H Fontaine; Emile Daraï; Bassam Haddad; Céline Méhats; Marcos Ballester; Geoffroy Canlorbe; Cyril Touboul
Journal:  J Transl Med       Date:  2018-05-21       Impact factor: 5.531

4.  HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells.

Authors:  Carolyn M Klinge; Kellianne M Piell; Christine Schaner Tooley; Eric C Rouchka
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

5.  Dysregulated lncRNA-miRNA-mRNA Network Reveals Patient Survival-Associated Modules and RNA Binding Proteins in Invasive Breast Carcinoma.

Authors:  Yu Dong; Yang Xiao; Qihui Shi; Chunjie Jiang
Journal:  Front Genet       Date:  2020-01-15       Impact factor: 4.599

6.  miR-137/ERRα axis mediates chemoresistance of nasopharyngeal carcinoma cells.

Authors:  Fei Liu; Chunsheng Gao; Wenjuan Wang; Jing Hu; Zuofeng Huang; Meng Liang; Shuo Li
Journal:  J Cell Commun Signal       Date:  2021-07-01       Impact factor: 5.782

7.  ERRα protein is stabilized by LSD1 in a demethylation-independent manner.

Authors:  Julie Carnesecchi; Catherine Cerutti; Jean-Marc Vanacker; Christelle Forcet
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

8.  Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.

Authors:  Guifang Yu; Jieheng Lin; Chengcheng Liu; Kailian Hou; Min Liang; Boyun Shi
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

9.  NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.

Authors:  Yueyue Wang; Lei Yan; Lingyu Zhang; Henan Xu; Tiantian Chen; Yu Li; Haifeng Wang; Sulian Chen; Wenrui Wang; Changjie Chen; Qingling Yang
Journal:  Int J Oncol       Date:  2018-07-09       Impact factor: 5.650

10.  Up-regulation of microRNA-497 inhibits the proliferation, migration and invasion but increases the apoptosis of multiple myeloma cells through the MAPK/ERK signaling pathway by targeting Raf-1.

Authors:  Cheng-Yu Ye; Cui-Ping Zheng; Wei-Wei Ying; Shan-Shan Weng
Journal:  Cell Cycle       Date:  2018-12-11       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.